Congress carves out biostimulants from EPA oversight—no safety review required

What it does

This bill amends federal pesticide law to create a consistent legal definition of 'plant biostimulants'—substances that improve plant growth and soil health without being classified as pesticides or fertilizers. It excludes biostimulants from EPA pesticide regulation, directs the EPA to update its rules within 120 days, and requires the Department of Agriculture to study which biostimulant practices best improve soil health and reduce nutrient runoff.

Why we flagged it

The bill's operative mechanism is to remove an entire product category (plant biostimulants) from EPA pesticide oversight by redefining it out of the regulatory framework. This is a deregulatory carve-out that benefits manufacturers and sellers of biostimulants by eliminating compliance costs and approval delays, while reducing public oversight.

What the text implies

• Biostimulants are excluded from EPA review even though they make claims about plant growth and stress tolerance—claims that resemble drug or pesticide efficacy statements. Consumers will have no federal agency verifying whether marketed benefits are real.
• The definition of 'plant biostimulant' is broad and self-referential (includes 'some plant biostimulants' in the nutritional chemical definition), creating potential ambiguity about what products qualify for the exemption and may invite regulatory arbitrage.
• The 120-day EPA rulemaking deadline is tight and may result in hastily drafted regulations that fail to establish clear boundaries, leaving manufacturers uncertain about compliance and regulators unable to enforce consistent standards.
• The USDA soil-health study is advisory only and does not bind EPA or manufacturers to any outcome; it may be used to lobby for further deregulation but creates no enforceable standards for product performance or environmental impact.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

Citizens may benefit from lower-cost, faster-to-market soil-health products and reduced regulatory delays on agricultural innovation. However, the exclusion of biostimulants from EPA oversight removes a safety and efficacy gate, potentially allowing unproven or misleading products to reach consumers without independent verification of claims.

Who stands to gain

• biostimulant manufacturers and distributors
• agricultural input suppliers
• biotech and microbial-product companies

Named in the bill

Environmental Protection Agency (EPA), Department of Agriculture (USDA), Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), Senate Committee on Agriculture, Nutrition, and Forestry

Where it stands

3 cosponsors: 2 Democrats, 1 Republicans.

• May 22, 2025 — Introduced · Congress.gov: “Introduced in Senate”
• May 22, 2025 — Referred to Senate Committee on Agriculture, Nutrition, and Forestry · Congress.gov: “Read twice and referred to the Committee on Agriculture, Nutrition, and Forestry”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.

Money around this bill

5 lobbying clients named this bill on 8 disclosure filings across 2 quarters, Dec 2025 to Jun 2026. Those filings disclosed $2,261,757 in lobbying spend. A filing names 14 bills on average, so that figure is what each filing reported, not a share belonging to this bill.

More lobbying clients named this bill than 78% of bills with at least one filing.

Roger Marshall, the sponsor, reported $1,735,891 in PAC receipts in the 2026 cycle.

• Consumer Brands Association (pka: Grocery Manufacturers Association) — $1,290,000 on 1 filing
• Agricultural Retailers Association — $630,000 on 3 filings
• The Fertilizer Institute — $316,757 on 1 filing
• Golf Course Superintendents Association of America — $25,000 on 2 filings
• Biological Products Industry Alliance (bpia) — $0 on 1 filing

Lobbying Disclosure Act filings through Jul 25, 2026. A filing shows who paid to lobby on a bill it names, not what changed.